Influence of isoproterenol and ouabain on excitation-contraction coupling, cross-bridge function, and energetics in failing human myocardium

Circulation

Volumn 94, Issue 12, 1996, Pages 3155-3160

  Hasenfuss, Gerd ^a   Mulieri, Louis A ^b   Allen, Paul D ^c   Just, H ^a   Alpert, N R ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF VERMONT   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

calcium; catecholamines; heart failure; inotropic agents; myocardium

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; CALCIUM; CARDIAC GLYCOSIDE; CATECHOLAMINE; CYCLIC AMP; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; ISOPRENALINE; ISOSORBIDE DINITRATE; MILRINONE; OUABAIN; PHOSPHATE; PHOSPHODIESTERASE INHIBITOR; QUINIDINE; WARFARIN;

ADULT; ARTICLE; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY TRANSFER; EXCITATION CONTRACTION COUPLING; FEMALE; FORCE; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE; HEAT; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SARCOLEMMA; SARCOPLASMIC RETICULUM;

EID: 0030454109     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3155     Document Type: Article

References (34)

1. Dies F, Krell MJ, Whitlow P, Liang C, Goldenberg I, Appelfeld MM, Gilbert EM. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation. 1986;74(suppl II):II-38. Abstract.
2. Uretsky BF, Jessup M, Konstam MA, Dec GW, Leier CV, Benotti J, Murali S, Herrmann HC, Sandberg JA for the Enoximone Multicenter Trial Group. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure: lack of benefit compared with placebo. Circulation. 1990;82:774-780.
3. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMets DL. Effect of oral milrinone on mortality in severe chronic heart failure: the Promise Study Research Group. N Engl J Med. 1991;325:1468-1475.
4. Woodley SL, Gilbert EM, Anderson JL, O'Connell JB, Deitchman D, Yanowitz FG, Mealey PC, Volkman K, Renlund DG, Menlove R, Bristow MR. β-Blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation. 1991;84:2426-2441.
5. Waagstein F, Bristow RM, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 1993;342:1441-1446.
6. CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 1994;90:1765-1773.
7. Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, Smith LK, Van Voorhees L, Gourley LA, Jolly MK. The Radiance Study: withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med. 1993;329:1-7.
8. Suga H. Ventricular energetics. Physiol Rev. 1990;70:247-276.
9. Suga H, Hisano R, Goto Y, Yamada O, Igarashi Y. Effect of positive inotropic agents on the relation between oxygen consumption and systolic pressure-volume area in canine left ventricle. Circ Res. 1983;53:306-318.
10. Goto Y, Slinker BK, LeWinter MM. Effects of amrinone and isoproterenol on mechanoenergetics of blood-perfused rabbit heart. Am J Physiol. 1992;262:H719-H727.
11. Nascimben L, Friedrich J, Liao R, Pauletto P, Pessina AC, Ingwall JS. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation. 1995;91:1824-1833.
12. Mulieri LA, Luhr G, Trefry J, Alpert NR. Metal-film thermopiles for use with rabbit right ventricular papillary muscles. Am J Physiol. 1977;233:C146-C156.
13. Mulieri LA, Hasenfuss G, Ittleman F, Blanchard EM, Alpert NR. Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime. Circ Res. 1989;65:1441-1444.
14. Mulieri LA, Leavitt BJ, Hasenfuss G, Allen PD. Alpert NR. Contraction frequency dependence of twitch and diastolic tension in human dilated cardiomyopathy. Basic Res Cardiol. 1992;87(suppl 1):199-212.
15. Hasenfuss G, Mulieri LA, Blanchard EM, Holubarsch C, Leavitt BJ, Ittleman F, Alpert NR. Energetics of isometric force development in control and volume-overload human myocardium: comparison with animal species. Circ Res. 1991;68:836-846.
16. Hasenfuss G, Mulieri LA, Leavitt BJ, Allen PD, Haeberle JR, Alpert NR. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ Res. 1992;70:1225-1232.
17. Alpert NR, Blanchard EM, Mulieri LA. Tension-independent heat in rabbit papillary muscle. J Physiol (Lond). 1989;414:433-453.
18. Hamrell BB, Panaanan R, Trono J, Alpert NR. A stable, sensitive, low-compliance capacitance force transducer. J Appl Physiol. 1975;38:190-193.
19. Hasenfuss G, Mulieri LA, Leavitt BJ, Alpert NR. Influence of isoproterenol on contractile protein function, excitation-contraction coupling, and energy turnover of isolated nonfailing human myocardium. J Mol Cell Cardiol. 1994;26:1461-1469.
20. Alpert NR, Mulieri LA, Hasenfuss G. Myocardial chemomechanical energy transduction. In: Fozzard HA, Haber E, Jennings RB, Katz AM, eds. The Heart and Cardiovascular System. New York, NY: Raven Press; 1992:111-128.
21. Hasenfuss G, Mulieri LA, Holubarsch C, Pieske B, Just H, Alpert NR. Energetics of calcium cycling in nonfailing and failing human myocardium. Basic Res Cardiol. 1992;87(suppl 2):81-92.
22. Huxley AF. Muscle structure and theories of contraction. Prog Biophys Biophys Chem. 1957;7:255-318.
23. Hajjar RJ, Gwathmey JK. Cross-bridge dynamics in human ventricular myocardium: regulation of contractility in the failing heart. Circulation. 1992;86:1819-1826.
24. 2+ on crossbridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction. Proc Natl Acad Sci U S A. 1988;85:3265-3269.
25. Brutsaert DL, Sys S. Relaxation and diastole of the heart. Physiol Rev. 1989;69:1228-1315.
26. Sys SU, Brutsaert DL. Diagnostic significance of impaired LV systolic relaxation in heart failure. Circulation. 1995;92:3377-3380.
27. Sheu SS. Cytosolic sodium concentration regulates contractility of cardiac muscle. Basic Res Cardiol. 1989;84(suppl 1):191-196.
28. Katz AM. Cyclic adenosine monophosphate effects on the myocardium: a man who blows hot and cold with one breath. J Am Coll Cardiol. 1983;2:143-149.
29. Beuckelmann DJ, Näbauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 1992;85:1046-1055.
30. Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich J, Posival H, Minami K, Just H, Hasenfuss G. Alterations in intra-cellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation. 1995;92:1169-1178.
31. 2+-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest. 1990;85:305-309.
32. 2+-ATP-ase in failing and nonfailing human myocardium, Circ Res. 1994; 75:434-442.
33. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 1995;92:778-784.
34. Mulieri LA, Leavitt BJ, Martin BJ. Haeberle JR, Alpert NR. Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin. Circulation. 1993;88:2700-2704.